Skip to Main Content

Paper Details

AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice model.
Physiological Reports
5
2021
786, 786-0, 786-0-Luc human RCC cells, AKT, AXL, AXL tyrosine kinase, BGB149, BGB324, Bemcentinib, Gas6, Ki67, RCC, RCC cells, RCCs, anti-AXL, antitumor, bemcentinib, cancer, cancer cell, cancers, human, human RCC cells, humanized, mice, nude mice, renal cell carcinoma, renal cell carcinomas, tilvestamab, tumors, tyrosine, tyrosine kinase, vimentin

Datasets

Release 1.2